HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Richard J. Shemin Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Shemin, R. J. Search for Related Content PubMed Articles by Shemin, R. J. Related Collections Related Article

Ann Thorac Surg 1999;67:1273
© 1999 The Society of Thoracic Surgeons

---

Invited Commentary

^a Department of Cardiothoracic Surgery, Boston University and, Boston Medical Center, 88 East Newton St, Boston, MA 02118-2393 USA

Invited commentary

This study of high-risk reoperative cardiac surgical patients adds to the growing literature that heparin-coated circuits are safe and adds significant benefit to patients requiring cardiopulmonary bypass for operations. Laboratory and clinical studies have consistently demonstrated a reduction in the measurable variables induced by the inflammatory response to cardiopulmonary bypass (ie, complement, leukocyte, cytokine, and platelet activation). Even though the biochemical data is compelling, reported clinical data have been . . . [Full Text of this Article]

Related Article

A prospective randomized trial of Duraflo II heparin-coated circuits in cardiac reoperations

Patrick M. McCarthy, Jean-Pierre P. Yared, Robert C. Foster, David A. Ogella, Judith A. Borsh, and Delos M. Cosgrove, III
Ann. Thorac. Surg. 1999 67: 1268-1273. [Abstract] [Full Text] [PDF]